Immunization is one of the most successful and cost-effective strategies for the prevention of infectious disease and was voted a top public health advance of the twentieth century by the public health community. Today we have vaccines that not only decrease incidence of the acute diseases such as hepatitis B or human papilloma virus (HPV), but consequently also decrease the serious sequelae of those infections, including hepatocellular carcinoma and cervical cancer. Never has gender medicine been so evident as in the development programs of the human papilloma vaccines. Early trials were targeted to woman (not men), despite the fact that interruption of viral disease transmission requires immunization to a large proportion of the population in order to achieve herd immunity. Moreover, HPV is associated with morbidity and mortality in men. While the major impact of immunization has historically been in children, important new vaccines target adults. This chapter reviews recent vaccine developments for adults including HPV, varicella zoster, infl uenza, hepatitis A and hepatitis B. Several vaccines for bacterial disease, including pneumococcus, pertussis (as a component of the tetanus and diphtheria vaccine), and meningococcus are also included. At the conclusion of this chapter is a discussion of immunization issues and pregnancy.
|Original language||English (US)|
|Title of host publication||Principles of Gender-Specific Medicine|
|Number of pages||20|
|State||Published - 2010|
All Science Journal Classification (ASJC) codes